Gregory J. Kato, MD

Gregory Kato, MD, a specialist in pediatric hematology and oncology at UPMC CancerCenter
  • Specialty:

  • Secondary Specialty:

    Medical Oncology Hematology
  • Board Certifications:

    Pediatric Hematology-Oncology
  • Education:

    MD, George Washington University Medical Center, Washington, DC
  • Residency:

    Childrens Hospital of Los Angeles, Los Angeles, CA
  • Fellowships:

    Johns Hopkins University School of Medicine, Baltimore, MD
  • Languages:



Gregory Kato, MD, is professor of Medicine, director of the Adult Sickle Cell Center of Excellence for the UPP Division of Hematology-Oncology, and director of the Vascular Medicine Institute/Institute for Transfusion Medicine Sickle Cell Center of Excellence. He treats nonmalignant hematology concerns in adults and specializes in adult and pediatric sickle cell disease. Dr. Kato's translational research focuses on the role of iron overload and angiogenic factors on pulmonary hypertension in sickle cell disease. In addition, Dr. Kato is a leader in early phase clinical trials in sickle cell disease.

Dr. Kato is board-certified in pediatric hematology-oncology. He received his medical degree from George Washington University School of Medicine and Health Sciences in Washington D.C. In addition, Dr. Kato completed his residency at Children's Hospital of Los Angeles and pediatric hematology-oncology fellowship at The Johns Hopkins Hospital, where he also served on the faculty. His most recent position was with the National Institutes of Health, and he is a member of the American Society of Hematology.